Trial site
Zhengzhou
- 16running trials
- 9closed trials
The trials here
What the 25 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia4 trials
- Multiple sclerosis3 trials
- Childhood cancers2 trials
- Coronary artery disease2 trials
- IgA nephropathy2 trials
- Psoriasis2 trials
- Acute lymphoblastic leukaemia1 trial
- ANCA-associated vasculitis1 trial
- Aplastic anaemia1 trial
- Chronic kidney disease1 trial
- Familial hypercholesterolaemia1 trial
- Immune thrombocytopenia (ITP)1 trial
- and 10 more
- Phase
- Phase 310 trials
- Phase 28 trials
- Phase 43 trials
- Status
- Active, not recruiting12 trials
- Completed9 trials
- Recruiting4 trials
- Lead sponsor
- Novartis Pharmaceuticals25 trials
Running trials
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Recruiting
Active, not recruiting
Inclisiran Effectiveness in China: a Pragmatic Randomized Trial
Recruiting
Active, not recruiting
Active, not recruiting
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers2 recruiting
- Chronic myeloid leukaemia2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Multiple sclerosis1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Completed
Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients
Site data: ClinicalTrials.govUpdated 13 Nov 2026